Cargando…

Conserved YKL-40 changes in mice and humans after postoperative delirium

Delirium is a common postoperative neurologic complication among older adults. Despite its prevalence (14%–50%) and likely association with inflammation, the exact mechanisms that underpin postoperative delirium are unclear. This project aimed to characterize systemic and central nervous system (CNS...

Descripción completa

Detalles Bibliográficos
Autores principales:	David-Bercholz, Jennifer, Acker, Leah, Caceres, Ana I., Wu, Pau Yen, Goenka, Saanvi, Franklin, Nathan O., Rodriguiz, Ramona M., Wetsel, William C., Devinney, Michael, Wright, Mary Cooter, Zetterberg, Henrik, Yang, Ting, Berger, Miles, Terrando, Niccolò
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706140/ https://www.ncbi.nlm.nih.gov/pubmed/36457825 http://dx.doi.org/10.1016/j.bbih.2022.100555

Ejemplares similares

Neurovascular and immune mechanisms that regulate postoperative delirium superimposed on dementia
por: Wang, Ping, et al.
Publicado: (2020)

Orthopedic Surgery Triggers Attention Deficits in a Delirium-Like Mouse Model
por: Velagapudi, Ravikanth, et al.
Publicado: (2019)

Protective effects of omega-3 fatty acids in a blood–brain barrier-on-chip model and on postoperative delirium-like behaviour in mice
por: Yang, Ting, et al.
Publicado: (2023)

A Role for Blood-brain Barrier Dysfunction in Delirium following Non-Cardiac Surgery in Older adults
por: Devinney, Michael J., et al.
Publicado: (2023)

The broad spectrum mixed-lineage kinase 3 inhibitor URMC-099 prevents acute microgliosis and cognitive decline in a mouse model of perioperative neurocognitive disorders
por: Miller-Rhodes, Patrick, et al.
Publicado: (2019)

Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults
por: Terrando, Niccolò, et al.
Publicado: (2021)

Annexin-A1 Tripeptide Attenuates Surgery-Induced Neuroinflammation and Memory Deficits Through Regulation the NLRP3 Inflammasome
por: Zhang, Zhiquan, et al.
Publicado: (2022)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999)

YKL-40 correlates with the phenotype of asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer’s Disease: A Pilot Study
por: Thordardottir, Steinunn, et al.
Publicado: (2020)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

YKL-40 Protein Correlates with the Phenotype of Asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
por: Hellwig, Konstantin, et al.
Publicado: (2015)

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease
por: Rosén, Christoffer, et al.
Publicado: (2014)

Preclinical and translational models for delirium: Recommendations for future research from the NIDUS delirium network
por: Vasunilashorn, Sarinnapha M., et al.
Publicado: (2023)

Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction
por: VanDusen, Keith W., et al.
Publicado: (2021)

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
por: Rathcke, Camilla N, et al.
Publicado: (2009)

Serum YKL-40 Levels in Patients with Gastric Cancer
por: Itik, Veyis, et al.
Publicado: (2011)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

YKL-40 as a possible marker of neutrophilic asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2023)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
por: Gevezova, Maria, et al.
Publicado: (2023)

Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
por: Hermansson, Linn, et al.
Publicado: (2019)

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
por: Shao, Rong, et al.
Publicado: (2009)

YKL-40 acts as an angiogenic factor to promote tumor angiogenesis
por: Shao, Rong
Publicado: (2013)

Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization
por: Shao, Rong, et al.
Publicado: (2015)

Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease
por: Schroder, Jakob, et al.
Publicado: (2020)

Effect of Vitamin D on YKL-40: Rat Hypercholesterolemia Model
por: Kocabas, Rahim
Publicado: (2023)

The G protein biased serotonin 5-HT 2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice
por: Pogorelov, Vladimir M., et al.
Publicado: (2023)

The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice
por: Pogorelov, Vladimir M., et al.
Publicado: (2023)

Neutrophilia with damage to the blood-brain barrier and neurovascular unit following acute lung injury
por: Li, Herman, et al.
Publicado: (2023)

Neutrophilia with damage to the blood-brain barrier and neurovascular unit following acute lung injury
por: Li, Herman, et al.
Publicado: (2023)

Prognostic implications of immunohistochemically detected YKL-40 expression in breast cancer
por: Kim, Steve H, et al.
Publicado: (2007)

YKL-40 levels are independently associated with albuminuria in type 2 diabetes
por: Røndbjerg, Anne K, et al.
Publicado: (2011)

YKL-40 tissue expression and plasma levels in patients with ovarian cancer
por: Høgdall, Estrid VS, et al.
Publicado: (2009)

Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension
por: Wang, Dong, et al.
Publicado: (2012)

Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma
por: Iwamoto, Fabio M., et al.
Publicado: (2014)

CTX-II and YKL-40 in early diagnosis and treatment evaluation of osteoarthritis
por: Wang, Pengkun, et al.
Publicado: (2019)

Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis
por: Jafari-Nakhjavani, Mohammad Reza, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ng4fligf4cm6btmnencvstiq18